241 related articles for article (PubMed ID: 37526710)
1. [Individualized precision medicine].
Wullich B; Taubert H; Goebell PJ; Kuwert T; Beck M; Schott C; Baur AS; Eckstein M; Wach S
Urologie; 2023 Sep; 62(9):879-888. PubMed ID: 37526710
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
5. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
7. Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.
Vellichirammal NN; Chaturvedi NK; Joshi SS; Coulter DW; Guda C
Cancer Lett; 2021 Feb; 499():24-38. PubMed ID: 33248210
[TBL] [Abstract][Full Text] [Related]
8. Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018.
Pisapia P; Bellevicine C; Malapelle U; De Luca C; Vigliar E; Troncone G
Cancer Cytopathol; 2019 Jun; 127(6):350-357. PubMed ID: 31135103
[TBL] [Abstract][Full Text] [Related]
9. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
Atreya CE; Yaeger R; Chu E
Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
[TBL] [Abstract][Full Text] [Related]
10. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
Lin PS; Semrad TJ
Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
[TBL] [Abstract][Full Text] [Related]
11. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
13. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
15. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
Supplitt S; Karpinski P; Sasiadek M; Laczmanska I
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572595
[TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free DNA-Diagnostic and Prognostic Applications in Personalized Cancer Therapy.
Oellerich M; Schütz E; Beck J; Walson PD
Ther Drug Monit; 2019 Apr; 41(2):115-120. PubMed ID: 30883505
[TBL] [Abstract][Full Text] [Related]
17. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
19. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
20. Cancer Biomarker Discovery for Precision Medicine: New Progress.
Zou J; Wang E
Curr Med Chem; 2019; 26(42):7655-7671. PubMed ID: 30027846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
